Prolymphocytic LeukemiaSymptoms, Doctors, Treatments, Advances & More
Prolymphocytic Leukemia Overview
Learn About Prolymphocytic Leukemia
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Michael Hallek practices practicing medicine in Koeln, Germany. Mr. Hallek is rated as an Elite expert by MediFind in the treatment of Prolymphocytic Leukemia. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Leukemia, Bone Marrow Transplant, and Bone Graft.
Stephan Stilgenbauer practices practicing medicine in Ulm, Germany. Mr. Stilgenbauer is rated as an Elite expert by MediFind in the treatment of Prolymphocytic Leukemia. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Leukemia, Bone Marrow Transplant, and Bone Graft.
Claire Dearden practices practicing medicine in London, United Kingdom. Ms. Dearden is rated as an Elite expert by MediFind in the treatment of Prolymphocytic Leukemia. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Hairy Cell Leukemia (HCL), Prolymphocytic Leukemia, Chronic T-Cell Leukemia (CTCL), Splenectomy, and Bone Marrow Transplant.
Summary: This phase I trial tests the safety, side effects and best infusion dose of genetically engineered cells called anti-CD19/CD20/CD22 chimeric antigen receptor (CAR) T-cells following a short course of chemotherapy with cyclophosphamide and fludarabine in treating patients with lymphoid cancers (malignancies) that have come back (recurrent) or do not respond to treatment (refractory). Lymphoid malig...
Summary: This phase II trial studies how well a donor stem cell transplant, treosulfan, fludarabine, and total-body irradiation work in treating patients with blood cancers (hematological malignancies). Giving chemotherapy and total-body irradiation before a donor stem cell transplant helps stop the growth of cells in the bone marrow, including normal blood-forming cells (stem cells) and cancer cells. It m...


